Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice

Hemophilia A (HA) is a blood clotting disorder that is caused by various genetic deficiencies in the factor VIII (FVIII)-encoding F8 gene. Patients receiving FVIII-replacement therapy are at risk for developing neutralizing antibodies (FVIII inhibitors), rendering the FVIII-replacement therapy ineff...

Descripción completa

Detalles Bibliográficos
Autores principales: Pletinckx, Katrien, Nicolson, Kirsty S., Streeter, Heather B., Sanderson, William J., Schurgers, Evelien, Jansson, Lotta, Wraith, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006293/
https://www.ncbi.nlm.nih.gov/pubmed/34529764
http://dx.doi.org/10.1182/bloodadvances.2021004451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006293/
https://www.ncbi.nlm.nih.gov/pubmed/34529764
http://dx.doi.org/10.1182/bloodadvances.2021004451

Ejemplares similares